| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/17/2005 | CN1655768A Oral dosage form for controlled drug release |
| 08/17/2005 | CN1655767A Coated particles with prolonged release and tablets containing same |
| 08/17/2005 | CN1655766A Sustained release of guaifenesin combination drugs |
| 08/17/2005 | CN1655765A Sustained release pharmaceutical preparations and methods for producing the same |
| 08/17/2005 | CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 08/17/2005 | CN1655763A Method for preparing polymer micelle pharmaceutical preparation containing drug for injection |
| 08/17/2005 | CN1655762A Ibuprofen suspension |
| 08/17/2005 | CN1655761A Modified release pharmaceutical formulation |
| 08/17/2005 | CN1655760A Immediate release pharmaceutical formulation |
| 08/17/2005 | CN1655740A Condom |
| 08/17/2005 | CN1654640A 超氧化物歧化酶组合物及其制备方法 Superoxide dismutase composition and its preparation method |
| 08/17/2005 | CN1654073A Paster for treating tinea unguium |
| 08/17/2005 | CN1654071A Biological fluid film of recombined human keratinized cell growth factor-2 and its preparing process |
| 08/17/2005 | CN1654070A Composite Chinese medicinal soft capsule for treating emmeniopathy and its preparing method |
| 08/17/2005 | CN1654068A Ointment for treating dermatosis |
| 08/17/2005 | CN1654062A Freeze dried powder injection for treating thromboangitis obliterans and its preparing process |
| 08/17/2005 | CN1654060A 'Kidney-Benefiting' glucose injection and its preparing process |
| 08/17/2005 | CN1654058A Medicine for treating chronic kidney failure and its preparing process |
| 08/17/2005 | CN1654057A Chinese medicine composition for treating acute cholecystitis and preparing method thereof |
| 08/17/2005 | CN1654056A Chinese medicine composition for peridentitis and preparing method thereof |
| 08/17/2005 | CN1654044A Chinese medicine for treating otitis media and its preparation |
| 08/17/2005 | CN1654042A Method for preparing natural organic silk worm protein for improving insulin excretion in diabetes patients |
| 08/17/2005 | CN1654039A Oral formulation of hydroxycamptothecin and its preparation method |
| 08/17/2005 | CN1654038A Buccal tablet of tea polyphenol for preventing and treating colds and resisting inflammation and preparation thereof |
| 08/17/2005 | CN1654037A Dispersible tablet of tamoxifen citrate and preparation method thereof |
| 08/17/2005 | CN1653951A Chinese date buccal tablet and its preparing process |
| 08/17/2005 | CN1214818C Copolymeric micelle drug compsn. and method for the prepn. thereof |
| 08/17/2005 | CN1214814C Capsule prepn for regulating blood fat and blood sugar |
| 08/17/2005 | CN1214812C Traditional Chinese medicine for treating femoral head necrosis |
| 08/17/2005 | CN1214809C Drip pills for curing aphtha and its preparing method |
| 08/17/2005 | CN1214802C Capsule for curing acne and its preparation process |
| 08/17/2005 | CN1214801C Face nursing and beautifying oral liquid |
| 08/17/2005 | CN1214798C Nocar ointment for treating herpes simplex and herpes zoster |
| 08/17/2005 | CN1214796C Method for preparing slow release micro pill of aspirin |
| 08/17/2005 | CN1214795C Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 08/17/2005 | CN1214792C Highly absorbable solid preparation |
| 08/17/2005 | CN1214791C Quinoline keto derivatives medicinal composition and its preparing method |
| 08/17/2005 | CN1214789C Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use |
| 08/17/2005 | CN1214785C Eyes-protecting transdermal acupoint plaster and it preparation method |
| 08/17/2005 | CN1214784C Quick-releasing tablet in vagina and its preparing method |
| 08/17/2005 | CN1214783C Method for producing controlled releasing drug formulation or its precursor, the drug formulation and the precursor |
| 08/17/2005 | CN1214782C W/O/W type polyphase emulsion |
| 08/17/2005 | CN1214781C Hybrid matrices and hybrid matrix mixtures |
| 08/16/2005 | US6930220 Adhering therapeutic tool |
| 08/16/2005 | US6930129 Orally administering a dosage form containing a central nervous system-acting drug in a pharmaceutically acceptable carrier, wherein said dosage release the drug at an ascending release rate for an extended time period |
| 08/16/2005 | US6930127 Veterinary treatment of ophthalmic disease in animals using topical tacrolimus |
| 08/16/2005 | US6930125 Activation of glutaminase; asthma therapy; reduction of pH |
| 08/16/2005 | US6930119 Liquid pharmaceutical composition |
| 08/16/2005 | US6930101 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/16/2005 | US6930092 Antibiotic agents |
| 08/16/2005 | US6930087 Pharmaceutical composition comprising factor VIII and neutral liposomes |
| 08/16/2005 | US6930085 G-type peptides to ameliorate atherosclerosis |
| 08/16/2005 | US6929955 Interactive system for presenting and eliminating substances |
| 08/16/2005 | US6929950 For implanting/transfecting monodispersed silicon particles joined to DNA into target tissue, cell or the blood stream |
| 08/16/2005 | US6929884 For controlled release, by dissolving cellulose in a polar solvent such as dimethylacetamide comprising an alkali metal salt, for example lithium chloride, dispersing the solid in the solution and gelling the solution with water to form a film |
| 08/16/2005 | US6929818 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/16/2005 | US6929805 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) |
| 08/16/2005 | US6929804 Once-a-day administering synergistic mixture |
| 08/16/2005 | US6929803 Dosage forms that permit the controlled release of liquid, active agent formulations |
| 08/16/2005 | US6929802 Method of cancer treatment |
| 08/16/2005 | US6929801 Antiparkinson agent, dermal penetration enhancer of a safe skin-tolerant sunscreen ester and a volatile liquid |
| 08/16/2005 | US6929797 Targeted therapeutic delivery of vitamin D compounds |
| 08/16/2005 | US6929793 Nutritional composition for treating an immune condition |
| 08/16/2005 | US6929790 Containing a zinc compound containing free available zinc ion and at least one stabilized oxidation potential raising compound, stored separately and mixed prior to using the oral composition. |
| 08/16/2005 | US6929636 Internal drug dispenser capsule medical device |
| 08/16/2005 | CA2355293C Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2337046C Sustained release pharmaceutical preparation |
| 08/16/2005 | CA2335363C Adhesively applied external nasal strips and dilators containing medications and fragrances |
| 08/16/2005 | CA2273094C Gel formulations for topical drug delivery |
| 08/16/2005 | CA2269707C Soluble form osmotic dose delivery system |
| 08/16/2005 | CA2258836C Adsorbent carrier used in direct hemoperfusion and method for reducing the particle size thereof |
| 08/16/2005 | CA2236164C Pulmonary surfactant peptide solubilization process |
| 08/16/2005 | CA2131350C Sustained release drug formulation containing a tramadol salt |
| 08/12/2005 | WO2005115609A1 Process for producing nanoparticle or nanostructure with use of nanoporous material |
| 08/11/2005 | WO2005073246A2 Method for preparing kl4 lung surfactant |
| 08/11/2005 | WO2005072803A1 Sublingual drug delivery device |
| 08/11/2005 | WO2005072776A2 Liposomal formulations of the antineoplastic agents |
| 08/11/2005 | WO2005072774A1 Vaginal compositions for treating infections |
| 08/11/2005 | WO2005072759A1 Effervescent composition including cranberry extract |
| 08/11/2005 | WO2005072751A1 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis |
| 08/11/2005 | WO2005072745A2 Aqueous solutions comprising prednisolone and a cyclodextrin derivative |
| 08/11/2005 | WO2005072736A2 Stable gabapentin compositions |
| 08/11/2005 | WO2005072727A1 Eye drop composition |
| 08/11/2005 | WO2005072717A1 Biguanide preparation for internal use |
| 08/11/2005 | WO2005072716A1 Plaster enclosing packaging bag |
| 08/11/2005 | WO2005072710A2 Drugs and gene carrier particles that rapidly move through mucous barriers |
| 08/11/2005 | WO2005072709A2 Formulations for poorly soluble drugs |
| 08/11/2005 | WO2005072708A1 Microcapsule with controllable or delayed release for immobilizing chemical and/or biological material in addition to method for the production thereof |
| 08/11/2005 | WO2005072707A1 Nanoparticle-containing composition and process for producing the same |
| 08/11/2005 | WO2005072706A2 Nanosuspensions of anti-retroviral agents for increased central nervous system delivery |
| 08/11/2005 | WO2005072705A1 Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions |
| 08/11/2005 | WO2005072704A2 Method of treating acute rhinosinusitis |
| 08/11/2005 | WO2005072703A2 Controlled and sustained delivery of nucleic acid-based therapeutic agents |
| 08/11/2005 | WO2005072702A2 Method for milling frozen microparticles |
| 08/11/2005 | WO2005072701A1 Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| 08/11/2005 | WO2005072700A2 Haemostatic sprays and compositions |
| 08/11/2005 | WO2005072699A1 Phase transformation in molecular solids |
| 08/11/2005 | WO2005072686A1 Dermatologic soft gel compositions |
| 08/11/2005 | WO2005072679A2 Adjuvant formulation containing an oily emulsion with jojoba oil |